CDEK
← All organizations

Bioenvision

For profitContributed to NME

Also known as: BIOENVISION | Bioenvision, Inc

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

Dec 1, 2003

Last known activity

Jun 1, 2004

Acquired by Genzyme → Sanofi-Aventis on Oct 1, 2007

Timeline

1980s

  1. Dec 31, 1984

    trilostane— Marketing Organization

  2. Dec 31, 1984

    trilostane— NDA Secondary Org

1990s

  1. Jun 1, 1996

    Bioenvision— Founded

2000s

  1. Oct 1, 2007

    Genzyme— Acquired By

2010s

  1. Jan 1, 2011

    Sanofi-Aventis— Now

Drugs by trial phase (1 distinct, 2 trials)

Phase 2 (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (2)

Details

Founded
New York, NY, US Jun 1, 1996
Last known activity
Jun 1, 2004